Low-Dose Antiangiogenic Therapy With Different Chemotherapy Backbones Among Patients With Heavily Pretreated Metastatic Breast Cancer.

Cancer Innov · 2026 · PMC13417479 · PMID 42529520

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

In our study, anlotinib combined with chemotherapy was associated with a numerical trend toward longer median PFS compared with chemotherapy alone.

also in 723 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.